1. Home
  2. OBIO vs NODK Comparison

OBIO vs NODK Comparison

Compare OBIO & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • NODK
  • Stock Information
  • Founded
  • OBIO 2017
  • NODK 1946
  • Country
  • OBIO United States
  • NODK United States
  • Employees
  • OBIO N/A
  • NODK N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • NODK Property-Casualty Insurers
  • Sector
  • OBIO Health Care
  • NODK Finance
  • Exchange
  • OBIO Nasdaq
  • NODK Nasdaq
  • Market Cap
  • OBIO 291.7M
  • NODK 309.4M
  • IPO Year
  • OBIO N/A
  • NODK 2017
  • Fundamental
  • Price
  • OBIO $8.64
  • NODK $15.99
  • Analyst Decision
  • OBIO Strong Buy
  • NODK
  • Analyst Count
  • OBIO 2
  • NODK 0
  • Target Price
  • OBIO $17.00
  • NODK N/A
  • AVG Volume (30 Days)
  • OBIO 251.6K
  • NODK 16.2K
  • Earning Date
  • OBIO 08-08-2024
  • NODK 08-06-2024
  • Dividend Yield
  • OBIO N/A
  • NODK N/A
  • EPS Growth
  • OBIO N/A
  • NODK N/A
  • EPS
  • OBIO N/A
  • NODK 0.24
  • Revenue
  • OBIO $2,216,000.00
  • NODK $375,489,000.00
  • Revenue This Year
  • OBIO $17.90
  • NODK N/A
  • Revenue Next Year
  • OBIO $10.51
  • NODK N/A
  • P/E Ratio
  • OBIO N/A
  • NODK $65.83
  • Revenue Growth
  • OBIO N/A
  • NODK 10.49
  • 52 Week Low
  • OBIO $4.22
  • NODK $12.01
  • 52 Week High
  • OBIO $11.69
  • NODK $16.55
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 63.78
  • NODK 67.96
  • Support Level
  • OBIO $7.48
  • NODK $14.89
  • Resistance Level
  • OBIO $8.75
  • NODK $15.30
  • Average True Range (ATR)
  • OBIO 0.60
  • NODK 0.22
  • MACD
  • OBIO 0.05
  • NODK 0.09
  • Stochastic Oscillator
  • OBIO 94.30
  • NODK 99.20

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.

Share on Social Networks: